Skye Bioscience, Inc. Common Stock (NASDAQ: SKYE) last traded at $1.69, up 0.60% on the session. The quote above updates while this page is open; the figures below are drawn from Skye Bioscience, Inc. Common Stock’s own filings and are restated only when a new one is published.
Skye Bioscience, Inc. Common Stock trades on NASDAQ under the ticker SKYE. Its market capitalisation is $59.86 million.
Valuation measures for Skye Bioscience, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $59.86M |
|---|---|
| Enterprise value | $63.32M |
| Beta | 0.99 |
Trailing-twelve-month figures tagged in Skye Bioscience, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$50.49M |
|---|---|
| EPS (TTM) |
| -$1.28 |
| Cash | $8.07M |
|---|
Range and volume for SKYE over the past 52 weeks.
| 52-week high | $13.60 |
|---|---|
| 52-week low | $1.50 |
| Volume | 18.7K |
| Average volume | 88.2K |
| Previous close | $1.68 |
Invest a chosen dollar amount in Skye Bioscience, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SKYE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.